Literature DB >> 20472351

Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery.

Arjun Sahgal1, Igor J Barani, Josef Novotny, Beibei Zhang, Paula Petti, David A Larson, Lijun Ma.   

Abstract

PURPOSE: Existing dose guidelines for intracranial stereotactic radiosurgery (SRS) are primarily based on single-target treatment data. This study investigated dose guidelines for multiple targets treated with SRS. METHODS AND MATERIALS: A physical model was developed to relate the peripheral isodose volume dependence on an increasing number of targets and prescription dose per target. The model was derived from simulated and clinical multiple brain metastatic cases treated with the Leksell Gamma Knife Perfexion at several institutions, where the total number of targets ranged from 2 to 60. The relative increase in peripheral isodose volumes, such as the 12-Gy volume, was studied in the multitarget treatment setting based on Radiation Therapy Oncology Group 90-05 study dose levels.
RESULTS: A significant increase in the 12-Gy peripheral isodose volumes was found in comparing multiple target SRS to single-target SRS. This increase strongly correlated (R(2) = 0.92) with the total number of targets but not the total target volumes (R(2) = 0.06). On the basis of the correlated curve, the 12-Gy volume for multiple target treatment was found to increase by approximately 1% per target when a low target dose such as 15 Gy was used, but approximately 4% per target when a high dose such as 20-24 Gy was used. Reduction in the prescription dose was quantified for each prescription level in maintaining the 12-Gy volume.
CONCLUSION: Normal brain dose increases predictably with increasing number of targets for multitarget SRS. A reduction of approximately 1-2 Gy in the prescribed dose is needed compared with single target radiosurgery. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20472351     DOI: 10.1016/j.ijrobp.2009.11.055

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Role of stereotactic radiosurgery for multiple (>4) brain metastases.

Authors:  John H Suh; Sam T Chao; Lily Angelov; Michael A Vogelbaum; Gene H Barnett
Journal:  J Radiosurg SBRT       Date:  2011

2.  The role of stereotactic radiosurgery and whole brain radiation therapy as primary treatment in the treatment of patients with brain oligometastases - A systematic review.

Authors:  Or Cohen-Inbar; Jason P Sheehan
Journal:  J Radiosurg SBRT       Date:  2016

Review 3.  Neurosurgical management of patients with brain metastasis.

Authors:  Mustafa Aziz Hatiboglu; Kerime Akdur; Raymond Sawaya
Journal:  Neurosurg Rev       Date:  2018-07-29       Impact factor: 3.042

4.  Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial.

Authors:  Raphael Bodensohn; Anna-Lena Kaempfel; Daniel Felix Fleischmann; Indrawati Hadi; Jan Hofmaier; Sylvia Garny; Michael Reiner; Robert Forbrig; Stefanie Corradini; Niklas Thon; Claus Belka; Maximilian Niyazi
Journal:  Strahlenther Onkol       Date:  2021-04-21       Impact factor: 3.621

5.  Radiotoxicity in robotic radiosurgery: proposing a new quality index for optimizing the treatment planning of brain metastases.

Authors:  Alexandra Hellerbach; Klaus Luyken; Mauritius Hoevels; Andreas Gierich; Daniel Rueß; Wolfgang W Baus; Martin Kocher; Maximilian I Ruge; Harald Treuer
Journal:  Radiat Oncol       Date:  2017-08-17       Impact factor: 3.481

6.  A simple knowledge-based tool for stereotactic radiosurgery pre-planning.

Authors:  Daniel S Goldbaum; Justin D Hurley; Russell J Hamilton
Journal:  J Appl Clin Med Phys       Date:  2019-11-19       Impact factor: 2.102

Review 7.  Radiation Necrosis from Stereotactic Radiosurgery-How Do We Mitigate?

Authors:  Balamurugan A Vellayappan; Tresa McGranahan; Jerome Graber; Lynne Taylor; Vyshak Venur; Richard Ellenbogen; Andrew E Sloan; Kristin J Redmond; Matthew Foote; Samuel T Chao; John H Suh; Eric L Chang; Arjun Sahgal; Simon S Lo
Journal:  Curr Treat Options Oncol       Date:  2021-06-07

8.  The impact of CyberKnife's prescription isodose percentage on intracranial target planning.

Authors:  Sung-Woo Lee; Sunyoung Jang; Anil P Pyakuryal; Kenneth Chang; Terence T Sio
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.